Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Dejaco, C; Duftner, C; Schirmer, M.
Frequency, Diagnostics and Therapy for Relapses in Polymyalgia Rheumatica
AKTUEL RHEUMATOL. 2014; 39(4): 238-240.
Doi: 10.1055/s-0034-1382037
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Dejaco Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- There are no generally accepted criteria for the classification of a relapse in polymyalgia rheumatica (PMR). In clinical studies, a relapse was defined as "recurrence of PMR characteristic symptoms" with or without increment of acute phase reactants. Around 50% of PMR patients suffer at least one relapse episode during their disease course. Advanced age, female sex, elevated erythrocyte sedimentation rate, increased plasma viscosity, high serum levels of soluble interleukin (IL)-6 receptor and persistently elevated C-reactive protein levels were associated with a higher relapse risk. The initial glucocorticoid dose as well as the subsequent tapering regimen also seem to play a role. A relapse of PMR is treated with an increment of corticosteroids to the pre-relapse dose. According to the British Society of Rheumatology guidelines, the addition of methotrexate may be considered in patients with frequent recurrences.
- Find related publications in this database (Keywords)
- polymyalgia rheumatic
- disease modifying antirheumatic drugs
- TNF-alpha inhibitors
- drug therapy